Clinical Trials Directory

Trials / Completed

CompletedNCT02331589

Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Chuncheon Sacred Heart Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Background: Korea red ginseng (KRG) has anti-carcinogenic activity, anti-oxidant activity, and cancer related anti-fatigue. Methods: Seventy five patients with non-alcoholic hepatitis were prospectively randomized to receive 3 weeks of KRG or placebo. Liver function test, pro-inflammatory cytokines, adiponectin, fatigue severity scale, and antioxidant activity were check and compared.

Detailed description

Fatigue Severity Scale We used to be KRUPP's fatigue severity scale. The survey has nine questions as following: (1) my motivation is lower, when I am fatigued (2) exercise brings on my fatigue (3) I am easily fatigued (4) fatigue interferes with my physical functioning (5) fatigue causes frequent problems for me (6) my fatigue prevents sustained physical functioning (7) fatigue interferes with carrying out certain duties and responsibilities (8) fatigue is among my 3 most disabling symptoms (9) fatigue interferes with my work, family, or social life. All subjects scored each question on a 7-point scale (1 = strongly disagree to 4 = neither disagree nor agree to 7 = strongly agree). All fatigue severity scale calculated and collected by one research nurse (C.W.K) in the Department of Internal Medicine.

Conditions

Interventions

TypeNameDescription
DRUGKRG (Korea Red ginseng)3 weeks of KRG capsule (3,000 mg/day)
DRUGPlacebo (for KRG)Placebos with same shape and size were manufactured and at Korea Ginseng Corporation

Timeline

Start date
2011-08-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2015-01-06
Last updated
2015-02-10
Results posted
2015-02-10

Source: ClinicalTrials.gov record NCT02331589. Inclusion in this directory is not an endorsement.